Pruritus Therapeutics Market: Investment Potential in Emerging Dermatology Treatments
The pruritus therapeutics market was valued at USD 8.63 billion in 2024 and is projected to reach USD 8.97 billion in 2025 and USD 12.61 billion by 2034, expanding at a CAGR of 5.50% during the forecast period 2025–2034. Key players include AbbVie Inc., Amgen Inc., Astellas Pharma Inc., Bristol Myers Squibb, Cara Therapeutics, GSK plc, Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical...
0 Σχόλια 0 Μοιράστηκε 69 Views 0 Προεπισκόπηση